Related Experiment Video

Updated: Aug 19, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Triterpenoid CDDO-Im downregulates PML/RARalpha expression in acute promyelocytic leukemia cells

T Ikeda1, F Kimura, Y Nakata

  • 1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

Cell Death and Differentiation
|March 5, 2005
PubMed

Insights

The novel compound CDDO-Im effectively targets acute promyelocytic leukemia (APL) cells by downregulating PML/RARalpha, enhancing ATRA differentiation, and sensitizing cells to ATO-induced apoptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • The triterpenoid CDDO induces tumor cell differentiation and apoptosis.
  • Acute promyelocytic leukemia (APL) is characterized by the PML/RARalpha fusion protein.

Purpose of the Study:

  • To investigate the effects of CDDO-Im on APL cells.
  • To determine the therapeutic potential of CDDO-Im in APL treatment.

Main Methods:

  • Treatment of NB4 and primary APL cells with CDDO-Im.
  • Analysis of PML/RARalpha expression, caspase activity, and apoptosis.
  • Assessment of APL cell sensitivity to ATRA and ATO.

Main Results:

  • CDDO-Im selectively downregulated PML/RARalpha via a caspase-dependent pathway.
  • CDDO-Im sensitized APL cells to ATRA-induced differentiation and ATO-induced apoptosis.
  • CDDO-Im disrupted redox balance and activated the extrinsic apoptotic pathway.

Conclusions:

  • CDDO-Im demonstrates significant therapeutic potential for APL treatment.
  • CDDO-Im acts through PML/RARalpha downregulation, enhanced ATRA differentiation, and ATO sensitization.
  • CDDO-Im represents a promising agent for APL therapy.

More Related Videos

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...